Carboplatin Accord 10 mg/ml concentraat voor oplossing voor infusie

DRUG2 trials

Sponsors

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Universitair Ziekenhuis Gent

Conditions

Stage IIIbreast cancermetastatic non-small-cell lung cancer

Phase 1

A phase 1b study of an autologous dendritic cell immunotherapy in combination with anti-programmed death-1 treatment in patients with metastatic non-small-cell lung cancer (DARE-LUNG)

Not yet recruitingCTIS2025-521577-13-00

Universitair Ziekenhuis Gentmetastatic non-small-cell lung cancer

Target: 64Updated: 2025-09-11

Phase 3

Substantially improving the cure rate of high-risk BRCA1-like breast cancer patients with personalized therapy (SUBITO) - an international randomized phase III trial

RecruitingCTIS2024-516196-32-00

Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichtingbreast cancer, Stage III

Start: 2017-01-01Target: 172Updated: 2025-01-29